Quebec City, Canada and Myrtle Beach, United States, November 27, 2017 – TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, sadly announced the death of Mr. Jean Lamarre, a member of the Board of Directors of TSO3. Mr. Lamarre contributed sound and constructive counsel on TSO3’s Board of Directors, and while leading TSO3’s Human Resources Committee. Mr. Lamarre was a pillar of the Canadian business community, holding several board positions, including the position of Board Chair for SEMAFO, and various other positions of significant responsibility with Groupe Lavalin and numerous other organizations.
“We are deeply saddened by the passing of our friend and colleague Jean Lamarre,” said Ric Rumble, TSO3’s President and Chief Executive Officer. “Jean always stressed that it is the people that make up a business, not just the technology. Through his leadership experience, broad business expertise and insights, Jean contributed greatly to TSO3, and he will be sorely missed. Our thoughts and prayers are with his family and friends.”
Founded in 1998, TSO3‘s activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
For more information about TSO3, visit the Company’s website at www.tso3.com.
– 30 –Back to Posts